Drug
Cipaglucosidase Alfa
Cipaglucosidase Alfa: highest development phase Phase 3, developed by Amicus Therapeutics. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Amicus Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cipaglucosidase Alfa NCT03911505 | Phase 3 | Pompe Disease (Late-onset) |
| Cipaglucosidase Alfa NCT03729362 | Phase 3 | Pompe Disease (Late-onset) |
| Cipaglucosidase alfa NCT04808505 | Phase 3 | Glycogen Storage Disease Type II Infantile Onset |
Latest
No recent events.
Follow Cipaglucosidase Alfa on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.